IL‐35 recombinant protein reverses inflammatory bowel disease and psoriasis through regulation of inflammatory cytokines and immune cells

Publisher: John Wiley & Sons Inc

E-ISSN: 1582-4934|22|2|1014-1025

ISSN: 1582-1838

Source: Journal of Cellular and Molecular Medicine, Vol.22, Iss.2, 2018-02, pp. : 1014-1025

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content